Table 2.
Targeted MS results for specific immune cell and select cytokine-related markers in ulcerative colitis
| Sample ID | Concentration (fmol/µg) | |||||||
| CD132 | IL17A | IL17RA | IL23 (p19) | IL23R | FOXP3 | CD8 | CD19 | |
| UC2 | 0.046 | – | 0.049 | – | – | 0.009 | 0.104 | – |
| UC3 | 0.041 | – | 0.052 | – | – | 0.008 | 0.136 | – |
| UC6 | 0.066 | – | 0.082 | – | – | 0.019 | 0.126 | – |
| UC7 | 0.063 | – | 0.061 | – | – | 0.005 | 0.173 | – |
| UC8 | 0.037 | – | 0.044 | – | – | – | 0.043 | – |
| UC9 | 0.050 | – | 0.049 | – | – | 0.015 | 0.170 | – |
| UC10 | 0.028 | – | 0.047 | – | – | – | 0.138 | – |
| UC11 | 0.064 | – | 0.052 | – | – | 0.004 | 0.063 | – |
| UC14 | 0.032 | – | 0.048 | – | – | 0.005 | 0.113 | – |
| UC16 | 0.053 | – | 0.041 | – | – | 0.013 | 0.103 | – |
| UC18 | 0.065 | – | 0.061 | – | – | 0.009 | 0.170 | 0.022 |
| UC20 | 0.054 | – | 0.062 | – | – | 0.018 | 0.167 | – |
| UC21 | 0.040 | – | 0.056 | – | – | 0.002 | 0.048 | – |
| UC22 | 0.059 | – | 0.071 | – | – | 0.014 | 0.108 | – |
| UC24 | 0.057 | – | 0.068 | – | – | 0.024 | 0.170 | 0.028 |
| UC25 | 0.064 | – | 0.052 | – | – | 0.022 | 0.181 | 0.049 |
| UC26 | 0.077 | – | 0.053 | – | – | 0.013 | 0.066 | 0.035 |
| UC27 | 0.047 | – | 0.057 | – | – | 0.009 | 0.294 | – |
| UC30 | 0.034 | – | 0.040 | – | – | 0.007 | 0.037 | – |
| UC36 | 0.017 | – | 0.023 | – | – | 0.006 | 0.026 | 0.004 |
| UC32 | 0.145 | – | 0.103 | – | – | 0.029 | 0.193 | 0.052 |
| UC38 | 0.063 | – | 0.040 | – | – | 0.012 | 0.109 | 0.065 |
'–', not detected; CD132, interleukin-2 receptor subunit gamma/common cytokine receptor gamma chain; FOXP3, forkhead box P3; IL17A, interleukin 17A; IL23 (p19), interleukin 23, alpha subunit p19; IL23R, interleukin 23 receptor; IL17RA, interleukin 17 receptor A; MS, mass spectrometry; UC, ulcerative colitis.